Vitamin D receptor polymorphisms among the Turkish population are associated with multiple sclerosis
References
- Kalman B, Toldy E. Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis. Neuromolecular Med. 2014; 16(2): 265-79.
- Librau RS, Singer SM, McDevitt HO. Th1 and Th2 CD41 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 1995; 16: 34–48.
- Hasheminia SJ, Tolouei S, Zarkesh-Esfahani SH, Shaygannejad V, Shirzad HA, Torabi R, Hashem Zadeh Chaloshtory M. Cytokines gene expression in newly diagnosed multiple sclerosis patients. Iran J Allergy Asthma Immunol. 2015; 14(2): 208-16.
- Brück W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol. 2005; 252(5):v3–9.
- García-Martín E, Agúndez JA, Martínez C, Benito-León J, Millán-Pascual J, Calleja P, et al. Vitamin D3 receptor (VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. PLoS One. 2013; 8(6): e65487.
- Herrero-Herranz E, Pardo LA, Gold R, Linker RA. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis. 2008; 30: 162–73.
- Huang J, Xie Z. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of case–control studies, Journal of the Neurological Sciences. 2012; 313: 79–85.
- Goldenberg MM. Multiple sclerosis review. P & T. 2012; 37(3): 175–84.
- Kurland LT. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. Amer. J. Hygiene. 1952; 55: 457–76.
- Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, et al. Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl. 2008; 188: 34–40.
- Martina B. Sintzel . Mark Rametta . Anthony T. Reder. Vitamin D and Multiple Sclerosis: A Comprehensive Review. Neurol Ther. 2018; 7: 59–85.
- Ebers GC, Kukay K, Bulmann DE, et al. A full genome search in multiple sclerosis. Nat Genet. 1996; 13: 472–6.
- Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosomes 6p21 and 17q22. Nat Genet. 1996; 13: 464–8.
- Fukazawaa T, Yabeb I, Kikuchib S, Sasakib H, Hamadaa T, Miyasaka K, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. Journal of the Neurological Sciences. 1999; 166: 47–52.
- Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA–DRB1*1501 is regulated by vitamin D. PloS Genet. 2009; 5: e1000369.
- Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheumatic Disease Clinics of North America. 2012; 38(1): 125–39.
- Jurutka PW, Bartik L, Whitfield GK, et al. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. Journal of Bone and Mineral Research. 2007; 22(2): v2-10.
- Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991; 87: 1103–7.
- Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA. 1996; 93: 7861–4.
- Meehan TF, DeLuca HF. The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice. Archives of Biochemistry and Biophysics. 2002; 408(2): 200–4.
- Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A. Positive Association of Vitamin D Receptor Gene Variations with Multiple Sclerosis in South East Iranian Population. Hindawi Publishing Corporation BioMed Research International. 2015; Article ID 427519: 1-4.
- Simon K, Munger K, Yang X, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis. 2010; 16(2): 133–8.
- Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner-Scott J. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler. 2012; 18(1): 16-22.
- Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. Journal of the Neurological Sciences. 2000; 177(1): 65–71.
- Tajouri L, Ovcaric M, Curtain R, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet. 2005; 19(1): 25–38.
- Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338: 143–56.
- McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001, 50: 121-127.
- Nasiri H, Forouzandeh M, Rasaee MJ and Rahbarizadeh F. Modified salting-out method: High-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal. 2005; 19(6): 229-32.
- Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert J, Hupperts R, Damoiseaux J. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmunity Reviews. 2009; 8: 621–6.
- Mamutse G, Woolmore J, Pye E, Partridge J, Boggild M, Young C, et al. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler. 2008; 14: 1280–3.
- Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, Thomson RJ, et al. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler. 2009; 15: 563–70.
- Partridge JM, Weatherby SJ, Woolmore JA, Highland DJ, Fryer AA, Mann CL, et al. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology. 2004; 62: 2323–5.
- Ozden Kamisli, Ceren Acar, Mert Sozen, Mehmet Tecellioglu, Fatma Ebru Yücel, Dilara Vaizoglu et al. The association between vitamin D receptor polymorphisms and multiple sclerosis in a Turkish population: Multiple Sclerosis and Related Disorders. 2018; 20: 78-81.
- Danyal Imani, Bahman Razi, Morteza Motallebnezhad, Ramazan Rezaei. Association between vitamin D receptor(VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis. Imani et al. BMC Neurology. 2019; (19): 339.
- Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ et al. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci. 2011; 305(1-2): 116-20.
DOI: https://doi.org/10.2478/bjmg-2022-0003 | Journal eISSN: 2199-5761
Language: English
Page range: 41 - 50
Published on: Mar 1, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2023 B Bulan, AY Hoscan, SN Keskin, A Cavus, EA Culcu, N Isik, EO List, A Arman, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.